Posted by | Posted in Cancer & Health News | Posted on 22-02-2010
HealthDay – FRIDAY, Feb. 19 (HealthDay News) — Rituxan (rituximab) has been
approved by the U.S. Food and Drug Administration to treat a slowly
progressing form of blood and bone marrow cancer known as chronic
lymphocytic leukemia (CLL), the agency said in a press release.
